Histostructural changes of rat cerebral cortex during hemorrhagic stroke modeling
Animal research · 2012
- What was studied
- Rat models of primary and secondary hemorrhagic stroke; brain histology
- Main finding
- Investigators reported fewer degenerating cortical neurons with the tested preparations.
Degenerative neurons after secondary stroke · 25.5 ± 0.8 cells/mm²
Reported findings and study design
Rat primary/secondary hemorrhagic-stroke model comparing Cerebrolysin, Cortexin and a separately named Cerebral preparation.
Population or model Rat models of primary and secondary hemorrhagic stroke; brain histology
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Degenerative neurons after secondary stroke | 25.5 ± 0.8 cells/mm² | |
| After Cerebrolysin | 17.6 ± 1.7 cells/mm² | |
| After Cortexin | 18.0 ± 0.9 cells/mm² | |
| After Cerebral comparator | 10.7 ± 0.4 cells/mm² | |
| Healthy-control value | 1.5 ± 0.1 cells/mm²; no more than 2% degenerative neurons |
Cerebral is a separate named comparator; its larger numerical effect is not attributed to Cerebrolysin or Cortexin.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Histological changes in rats do not establish human functional recovery or safety in brain hemorrhage.
- A separately named preparation, Cerebral, is not treated as interchangeable with Cortexin or Cerebrolysin.
Source details
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Abstract reviewed
Sources checked
Citation
Savos'ko SI, Chaĭkovs'kyĭ IuB, Pogoriela NKh, Makarenko OM. Histostructural changes of rat cerebral cortex during hemorrhagic stroke modeling Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) · PMID 23233944
Related compounds
Cortexin
A polypeptide extract of animal cerebral cortex. Its active material is a mixture of low-molecular-weight peptides studied in neurological rehabilitation, stroke and pediatric neurology.
Cerebrolysin
An injectable hydrolysate of porcine brain tissue containing small peptides and free amino acids. Clinical studies have examined recovery after stroke and cognition in Alzheimer’s disease.